General Atlantic Genpar (bermuda), L.P., 10% Owner, Director at Centessa Pharmaceuticals plc (CNTA), bought 1,500,000 shares at $20.00 ($30.0M) on 2021-06-02, disclosed to the SEC on 2021-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ALKT | BUY | 2026-03-16 | $9.2M | — | Filing → |
| ALKT | BUY | 2026-03-11 | $50.6M | — | Filing → |
| ALKT | SELL | 2024-11-27 | $119.3M | — | Filing → |